The call ran from 6:31 PM to 6:57 PM IST (26 min).
Key takeaways
Record Q2 FY27: revenue up 24.7% to about ₹373 Cr, EBITDA up 36.6%, margin 17.6%. Reported H1 PAT up only 7.5% due to a prior-year one-off tax credit; ex-it about 39%. Gross margin fell 170 bps on traded-product mix.
| Revenue growth | Q2 revenue +24.7% to ~₹373 Cr; constant-currency ~16%. |
|---|---|
| Margins | EBITDA margin 16% to 17.6% in Q2; gross margin down 170 bps H1. |
| Demand visibility | Growth across all categories and regions; Europe 23%, India 15%. |
| Management confidence | Upbeat, 'record quarter' framing, though margin pressure acknowledged. |
Growth
Constant-currency Q2 growth ~16% vs reported 24.7%, currency aided. H1 EBITDA +43.4%; gross margin down 170 bps.
Outlook
EBITDA margin +150–200 bps yearly; ~20% by FY29. Constant-currency revenue growth mid-to-high teens; capex ~₹70 Cr FY27–28.
Risks
Gross margin down 170 bps on traded mix and input costs. Reported H1 PAT +7.5%; ETR 32–35% for two to three years.
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Sahajanand Medical Technologies Q2 FY27 Results: Net Profit ₹26.5 Cr, Up 26.8% YoY
Sahajanand Medical Technologies Ltd reported revenue from operations of ₹373.4 Cr (+24.7% YoY) and net profit of ₹26.5 Cr (+26.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.5 Cr · +26.8% YoY
Call details
| Company | Sahajanand Medical Technologies Ltd |
|---|---|
| NSE symbol | SMT |
| ISIN | INE356Y01018 |
| Call | Q2 FY27 earnings call |
| Date | Thursday, 5 November 2026 |
| Time | 6:30 PM IST |
| Length | 26 min |
| Audio | Our stream on YouTube ↗ |
Sahajanand Medical Technologies Ltd: key numbers
- Share price
- ₹487.75
- Market cap
- ₹4,958 Cr
- Revenue (annual)
- ₹1,210 Cr
- Net profit (annual)
- ₹65.28 Cr
- Promoter holding
- 36.20%
- FII holding
- 35.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Thu, 5 Nov
Today's concalls →
